{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:28:00Z","timestamp":1787041680085,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41401-026-01809-6","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T03:15:06Z","timestamp":1779074106000},"page":"2603-2618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PGK1 epigenetically silences STING via DNMT1 and its knockdown synergizes with STING agonists in pancreatic cancer"],"prefix":"10.1038","volume":"47","author":[{"given":"Wan-mei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-yong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"1809_CR1","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"1809_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman MH, Beatty GL. Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance. Annu Rev Pathol. 2023;18:123\u201348.","journal-title":"Annu Rev Pathol"},{"key":"1809_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541\u201350.","journal-title":"Nat Med"},{"key":"1809_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear AS, Vonderheide RH, O\u2019Hara MH. Challenges and opportunities for pancreatic cancer immunotherapy. Cancer Cell. 2020;38:788\u2013802.","journal-title":"Cancer Cell"},{"key":"1809_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer. 2016;16:635\u201349.","journal-title":"Nat Rev Cancer"},{"key":"1809_CR6","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1172\/JCI69600","volume":"123","author":"CT Hensley","year":"2013","unstructured":"Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest. 2013;123:3678\u201384.","journal-title":"J Clin Invest"},{"key":"1809_CR7","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","volume":"24","author":"A Luengo","year":"2017","unstructured":"Luengo A, Gui DY, Vander Heiden MG. Targeting metabolism for cancer therapy. Cell Chem Biol. 2017;24:1161\u201380.","journal-title":"Cell Chem Biol"},{"key":"1809_CR8","doi-asserted-by":"crossref","unstructured":"Qin W, Duan Y, Hu Z, Hou Y, Wen T, Ouyang Y, et al. PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion. J Exp Med. 2025;222:e20240902.","DOI":"10.1084\/jem.20240902"},{"key":"1809_CR9","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","volume":"34","author":"D Guo","year":"2022","unstructured":"Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1. Cell Metab. 2022;34:1312\u201324.e6.","journal-title":"Cell Metab"},{"key":"1809_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13601-8","volume":"11","author":"H Nie","year":"2020","unstructured":"Nie H, Ju H, Fan J, Shi X, Cheng Y, Cang X, et al. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat Commun. 2020;11:36.","journal-title":"Nat Commun"},{"key":"1809_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.682461","volume":"11","author":"R Gou","year":"2021","unstructured":"Gou R, Hu Y, Liu O, Dong H, Gao L, Wang S, et al. PGK1 is a key target for anti-glycolytic therapy of ovarian cancer: based on the comprehensive analysis of glycolysis-related genes. Front Oncol. 2021;11:682461.","journal-title":"Front Oncol"},{"key":"1809_CR12","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1159\/000495900","volume":"51","author":"D Fu","year":"2018","unstructured":"Fu D, He C, Wei J, Zhang Z, Luo Y, Tan H, Ren C. PGK1 is a potential survival biomarker and invasion promoter by regulating the HIF-1\u03b1-mediated epithelial-mesenchymal transition process in breast cancer. Cell Physiol Biochem. 2018;51:2434\u201344.","journal-title":"Cell Physiol Biochem"},{"key":"1809_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04576-4","volume":"13","author":"Y He","year":"2022","unstructured":"He Y, Wang X, Lu W, Zhang D, Huang L, Luo Y, et al. PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4\/ERK signaling pathway and accelerating glycolysis. Cell Death Dis. 2022;13:118.","journal-title":"Cell Death Dis"},{"key":"1809_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117863","volume":"256","author":"Q Fu","year":"2020","unstructured":"Fu Q, Yu Z. Phosphoglycerate kinase 1 (PGK1) in cancer: a promising target for diagnosis and therapy. Life Sci. 2020;256:117863.","journal-title":"Life Sci"},{"key":"1809_CR15","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.molcel.2018.09.007","volume":"72","author":"X Li","year":"2018","unstructured":"Li X, Qian X, Jiang H, Xia Y, Zheng Y, Li J, et al. Nuclear PGK1 alleviates ADP-dependent inhibition of CDC7 to promote DNA replication. Mol Cell. 2018;72:650\u201360.e8.","journal-title":"Mol Cell"},{"key":"1809_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.molcel.2016.02.009","volume":"61","author":"X Li","year":"2016","unstructured":"Li X, Jiang Y, Meisenhelder J, Yang W, Hawke DH, Zheng Y, et al. Mitochondria-translocated PGK1 functions as a protein kinase to coordinate glycolysis and the TCA cycle in tumorigenesis. Mol Cell. 2016;61:705\u201319.","journal-title":"Mol Cell"},{"key":"1809_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04499-0","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Yu H, Zhang T, Guo L, Xu J, et al. PGK1 represses autophagy-mediated cell death to promote the proliferation of liver cancer cells by phosphorylating PRAS40. Cell Death Dis. 2022;13:68.","journal-title":"Cell Death Dis"},{"key":"1809_CR18","doi-asserted-by":"crossref","unstructured":"Lu Y, Zhao N, Wu Y, Yang S, Wu Q, Dong Q, et al. Inhibition of PGK1 attenuates autoimmune myocarditis by reprogramming CD4+ T cells metabolism. Cardiovasc Res. 2023;119:1377\u201389.","DOI":"10.1093\/cvr\/cvad029"},{"key":"1809_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12931-024-02926-8","volume":"25","author":"G Zhu","year":"2024","unstructured":"Zhu G, Yu H, Peng T, Yang K, Xu X, Gu W. Glycolytic enzyme PGK1 promotes M1 macrophage polarization and induces pyroptosis of acute lung injury via regulation of NLRP3. Respir Res. 2024;25:291.","journal-title":"Respir Res"},{"key":"1809_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174835","volume":"920","author":"H Liu","year":"2022","unstructured":"Liu H, Wang X, Shen P, Ni Y, Han X. The basic functions of phosphoglycerate kinase 1 and its roles in cancer and other diseases. Eur J Pharm. 2022;920:174835.","journal-title":"Eur J Pharm"},{"key":"1809_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40880-019-0401-9","volume":"39","author":"F Shao","year":"2019","unstructured":"Shao F, Yang X, Wang W, Wang J, Guo W, Feng X, et al. Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis. Cancer Commun. 2019;39:54.","journal-title":"Cancer Commun"},{"key":"1809_CR22","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1002\/pmic.200500345","volume":"6","author":"T-L Hwang","year":"2006","unstructured":"Hwang TL, Liang Y, Chien KY, Yu JS. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma. Proteomics. 2006;6:2259\u201372.","journal-title":"Proteomics"},{"key":"1809_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05679-2","volume":"14","author":"G Quan","year":"2023","unstructured":"Quan G, Xu J, Wang J, Liu X, Xu J, Jiang J. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer. Cell Death Dis. 2023;14:137.","journal-title":"Cell Death Dis"},{"key":"1809_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"1809_CR25","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.7150\/ijbs.58886","volume":"17","author":"X Zhao","year":"2021","unstructured":"Zhao X, Li H, Lyu S, Zhai J, Ji Z, Zhang Z, et al. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma. Int J Biol Sci. 2021;17:2590\u2013605.","journal-title":"Int J Biol Sci"},{"key":"1809_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00448-9","volume":"19","author":"T Tian","year":"2024","unstructured":"Tian T, Leng Y, Tang B, Dong X, Ren Q, Liang J, et al. The oncogenic role and regulatory mechanism of PGK1 in human non-small cell lung cancer. Biol Direct. 2024;19:1.","journal-title":"Biol Direct"},{"key":"1809_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/cbin.11744","volume":"46","author":"S Liu","year":"2022","unstructured":"Liu S, Song L, Yao H, Zhang L. HPV16 E6\/E7 stabilize PGK1 protein by reducing its poly-ubiquitination in cervical cancer. Cell Biol Int. 2022;46:370\u201380.","journal-title":"Cell Biol Int"},{"key":"1809_CR28","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/annonc\/mdu191","volume":"25","author":"HR Ali","year":"2014","unstructured":"Ali HR, Provenzano E, Dawson SJ, Blows FM, Liu B, Shah M, et al. Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. Ann Oncol. 2014;25:1536\u201343.","journal-title":"Ann Oncol"},{"key":"1809_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124:359\u201367.","journal-title":"Br J Cancer"},{"key":"1809_CR30","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960\u20134.","journal-title":"Science"},{"key":"1809_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik I, Whisstock JC, Trapani JA. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15:388\u2013400.","journal-title":"Nat Rev Immunol"},{"key":"1809_CR32","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm.3708","volume":"20","author":"A Sistigu","year":"2014","unstructured":"Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med. 2014;20:1301\u20139.","journal-title":"Nat Med"},{"key":"1809_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nri3845","volume":"15","author":"L Zitvogel","year":"2015","unstructured":"Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015;15:405\u201314.","journal-title":"Nat Rev Immunol"},{"key":"1809_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","volume":"564","author":"JM Ramanjulu","year":"2018","unstructured":"Ramanjulu JM, Pesiridis GS, Yang J, Concha N, Singhaus R, Zhang SY, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature. 2018;564:439\u201343.","journal-title":"Nature"},{"key":"1809_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100\u20135.","journal-title":"Nature"},{"key":"1809_CR36","doi-asserted-by":"crossref","unstructured":"Falahat R, Berglund A, Putney RM, Perez-Villarroel P, Aoyama S, Pilon-Thomas S, et al. Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma. Proc Natl Acad Sci USA. 2021;118:e2013598118.","DOI":"10.1073\/pnas.2013598118"},{"key":"1809_CR37","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-018-0622-0","volume":"562","author":"MJ Bollong","year":"2018","unstructured":"Bollong MJ, Lee G, Coukos JS, Yun H, Zambaldo C, Chang JW, et al. A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature. 2018;562:600\u20134.","journal-title":"Nature"},{"key":"1809_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41401-020-0465-8","volume":"42","author":"W-L Wang","year":"2021","unstructured":"Wang WL, Jiang ZR, Hu C, Chen C, Hu ZQ, Wang AL, et al. Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52. Acta Pharmacol Sin. 2021;42:633\u201340.","journal-title":"Acta Pharmacol Sin"},{"key":"1809_CR39","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41388-017-0120-0","volume":"37","author":"H Konno","year":"2018","unstructured":"Konno H, Yamauchi S, Berglund A, Putney RM, Mul\u00e9 JJ, Barber GN. Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production. Oncogene. 2018;37:2037\u201351.","journal-title":"Oncogene"},{"key":"1809_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114033","volume":"157","author":"H Zheng","year":"2023","unstructured":"Zheng H, Wu L, Xiao Q, Meng X, Hafiz A, Yan Q, et al. Epigenetically suppressed tumor cell intrinsic STING promotes tumor immune escape. Biomed Pharmacother. 2023;157:114033.","journal-title":"Biomed Pharmacother"},{"key":"1809_CR41","doi-asserted-by":"crossref","unstructured":"Tu Y, Zhu QY, Huang WJ, Feng S, Tan YL, Li LL, et al. DNMT inhibition epigenetically restores the cGAS-STING pathway and activates RIG-I\/MDA5-MAVS to enhance antitumor immunity. Acta Pharmacol Sin. 2026;47:197\u2013208.","DOI":"10.1038\/s41401-025-01639-y"},{"key":"1809_CR42","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","volume":"21","author":"JK Christman","year":"2002","unstructured":"Christman JK. 5-Azacytidine and 5-aza-2\u2019-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21:5483\u201395.","journal-title":"Oncogene"},{"key":"1809_CR43","doi-asserted-by":"publisher","first-page":"ra80","DOI":"10.1126\/scisignal.2001462","volume":"3","author":"Z Du","year":"2010","unstructured":"Du Z, Song J, Wang Y, Zhao Y, Guda K, Yang S, et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal. 2010;3:ra80.","journal-title":"Sci Signal"},{"key":"1809_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nchembio.1657","volume":"11","author":"X Chen","year":"2015","unstructured":"Chen X, Zhao C, Li X, Wang T, Li Y, Cao C, et al. Terazosin activates Pgk1 and Hsp90 to promote stress resistance. Nat Chem Biol. 2015;11:19\u201325.","journal-title":"Nat Chem Biol"},{"key":"1809_CR45","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4161\/cbt.8.10.8213","volume":"8","author":"W Fiskus","year":"2009","unstructured":"Fiskus W, Buckley K, Rao R, Mandawat A, Yang Y, Joshi R, et al. Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells. Cancer Biol Ther. 2009;8:939\u201350.","journal-title":"Cancer Biol Ther"},{"key":"1809_CR46","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/1541-7786.MCR-07-0330","volume":"6","author":"Q Zhou","year":"2008","unstructured":"Zhou Q, Agoston AT, Atadja P, Nelson WG, Davidson NE. Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells. Mol Cancer Res. 2008;6:873\u201383.","journal-title":"Mol Cancer Res"},{"key":"1809_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/cr.2016.149","volume":"27","author":"L Corrales","year":"2017","unstructured":"Corrales L, Matson V, Flood B, Spranger S, Gajewski TF. Innate immune signaling and regulation in cancer immunotherapy. Cell Res. 2017;27:96\u2013108.","journal-title":"Cell Res"},{"key":"1809_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137.","journal-title":"Cancer Treat Rev"},{"key":"1809_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8458","volume":"6","author":"ME Mikucki","year":"2015","unstructured":"Mikucki ME, Fisher DT, Matsuzaki J, Skitzki JJ, Gaulin NB, Muhitch JB, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458.","journal-title":"Nat Commun"},{"key":"1809_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","volume":"40","author":"E Limagne","year":"2022","unstructured":"Limagne E, Nuttin L, Thibaudin M, Jacquin E, Aucagne R, Bon M, et al. MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells. Cancer Cell. 2022;40:136\u201352.e12.","journal-title":"Cancer Cell"},{"key":"1809_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.gastro.2015.04.010","volume":"149","author":"GL Beatty","year":"2015","unstructured":"Beatty GL, Winograd R, Evans RA, Long KB, Luque SL, Lee JW, et al. Exclusion of T cells from pancreatic carcinomas in mice is regulated by Ly6C(low) F4\/80+ extratumoral macrophages. Gastroenterology. 2015;149:201\u201310.","journal-title":"Gastroenterology"},{"key":"1809_CR52","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1136\/gutjnl-2013-306271","volume":"63","author":"IM Stromnes","year":"2014","unstructured":"Stromnes IM, Brockenbrough JS, Izeradjene K, Carlson MA, Cuevas C, Simmons RM, et al. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity. Gut. 2014;63:1769\u201381.","journal-title":"Gut"},{"key":"1809_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/gutjnl-2016-312078","volume":"66","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Velez-Delgado A, Mathew E, Li D, Mendez FM, Flannagan K, et al. Myeloid cells are required for PD-1\/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124\u201336.","journal-title":"Gut"},{"key":"1809_CR54","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2017.01.027","volume":"65","author":"X Qian","year":"2017","unstructured":"Qian X, Li X, Cai Q, Zhang C, Yu Q, Jiang Y, et al. Phosphoglycerate Kinase 1 phosphorylates Beclin1 to induce autophagy. Mol Cell. 2017;65:917\u2013931.e6.","journal-title":"Mol Cell"},{"key":"1809_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tcb.2022.06.010","volume":"33","author":"EN Chin","year":"2023","unstructured":"Chin EN, Sulpizio A, Lairson LL. Targeting STING to promote antitumor immunity. Trends Cell Biol. 2023;33:189\u2013203.","journal-title":"Trends Cell Biol"},{"key":"1809_CR56","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"S-R Woo","year":"2014","unstructured":"Woo S-R, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MYK, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014;41:830\u201342.","journal-title":"Immunity"},{"key":"1809_CR57","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 2015;11:1018\u201330.","journal-title":"Cell Rep"},{"key":"1809_CR58","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1172\/JCI127471","volume":"129","author":"Z Wang","year":"2019","unstructured":"Wang Z, Chen J, Hu J, Zhang H, Xu F, He W, et al. cGAS\/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity. J Clin Invest. 2019;129:4850\u201362.","journal-title":"J Clin Invest"},{"key":"1809_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","volume":"9","author":"T Sen","year":"2019","unstructured":"Sen T, Rodriguez BL, Chen L, Della Corte CM, Morikawa N, Fujimoto J, et al. Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer. Cancer Discov. 2019;9:646\u201361.","journal-title":"Cancer Discov"},{"key":"1809_CR60","doi-asserted-by":"crossref","unstructured":"Lu Y, Yurkevicz AM, Liu Y, Glazer PM. Hypoxia induces immunosuppression by silencing STING in cancer. Cancer Res. 2025;85:4664\u201380.","DOI":"10.1158\/0008-5472.CAN-24-2038"},{"key":"1809_CR61","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrc2468","volume":"8","author":"NC Denko","year":"2008","unstructured":"Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2008;8:705\u201313.","journal-title":"Nat Rev Cancer"},{"key":"1809_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s10020-019-0079-0","volume":"25","author":"J-W Zhou","year":"2019","unstructured":"Zhou JW, Tang JJ, Sun W, Wang H. PGK1 facilities cisplatin chemoresistance by triggering HSP90\/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma. Mol Med. 2019;25:11.","journal-title":"Mol Med"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01809-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01809-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01809-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:04:45Z","timestamp":1787040285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01809-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1809"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01809-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}